Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$4.01−3.84%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $19.1M
- 52-week range
- $2.58 – $55.90
- 52-week change
- −90.07%
- EPS (trailing)
- −$16.87
Fiscal year to Dec 2025
- Net income
- −$11.7M
- Diluted EPS
- −$7.16
From the company’s annual report on SEC EDGAR.
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Headquarters: Gaithersburg, United States · 2 employees · shuttlepharma.com